Cdk2-dependent and -independent pathways in E2F-mediated S phase induction

Y Arata1, M Fujita, K Ohtani

  • 1Graduate School of Biological Sciences, Nara Institute of Science and Technology, 8916-5 Takayama, Ikoma, Nara 630-0101, Japan.

Insights

The transcription factor E2F initiates DNA replication by activating two distinct pathways. One pathway requires cyclin-dependent kinase 2 (Cdk2) activity, while the other does not, revealing new insights into cell cycle regulation.

Area of Science:

  • Molecular Biology
  • Cell Cycle Regulation
  • DNA Replication

Background:

  • The transcription factor E2F is crucial for the G(1) to S phase transition in eukaryotic cell cycles.
  • While E2F-inducible genes are known, the precise molecular mechanisms linking E2F to S phase entry require further elucidation.
  • Understanding these pathways is key to comprehending DNA replication initiation.

Purpose of the Study:

  • To investigate the molecular mechanisms by which E2F-1 mediates the initiation of chromosomal DNA replication.
  • To identify the specific downstream pathways activated by E2F-1 that lead to S phase entry.
  • To differentiate the roles of Cdk2 and other factors in E2F-1-induced DNA replication.

Main Methods:

  • Generated stably transfected mouse NIH3T3 cells expressing human E2F-1 under a metallothionein promoter.
  • Analyzed G(1) to S phase progression, cyclin and Cdk activity, and the chromatin association of replication proteins.
  • Utilized Cdk inhibitory proteins (p27, p18, p19) and a Cdk-specific inhibitor (butyrolactone I).

Main Results:

  • Ectopic E2F-1 expression induced G(1) progression and S phase entry, with induced expression of cyclin E and activation of Cdk2.
  • Cdk2 activity, but not Cdk4, was essential for E2F-1-mediated S phase entry.
  • Ectopic E2F-1 expression was required for the chromatin association of Minichromosome maintenance proteins (MCM) 4 and 7, and induced expression and chromatin binding of Cdc45.
  • Cdk2 activity was necessary for Cdc45 chromatin binding but not for Cdc45 expression or MCM4/7 chromatin binding.

Conclusions:

  • E2F-1 initiates S phase through at least two distinct downstream pathways.
  • One pathway is dependent on Cdk2 activity, likely for Cdc45 recruitment to chromatin.
  • The second pathway is independent of Cdk2 activity, potentially regulating MCM4 and MCM7 chromatin association.

Related Concept Videos

Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...